Look for:

Our offer for

SHL TELEMEDICINE LTD


ISIN:
IL0010855885
WKN:
1128957

2024/08/15 17:31:33
Price
3.40 CHF
Difference -3.95% (-0.14)

General attributes

ISINIL0010855885
SymbolSHLTN
ExchangeSIX Swiss Exchange
CurrencyCHF
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)58 EUR
BenchmarkMSCI WORLD INDEX (STRD, UHD)

Market data

Bid (Bid size)3.02 CHF (8)
Ask (Ask size)3.56 CHF (1)
Open3.40 CHF
High3.53 CHF
Low3.40 CHF
Close (prev. day)3.54 CHF
VWAP3.400688 CHF
Volume (pcs)1,134
Trading volume3,856.38
Number of trades6
Last size-

Futures and Options

Related Futures-
Related Options-

PDF Downloads

Company report: SHL TELEMEDICINE LTDPDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research

Date Headline Download
2024/08/12 en Global Equity Ratings PDF Download
2024/07/24 en Global Equity Ratings PDF Download
2024/07/12 en Global Equity Ratings PDF Download
2024/06/21 en Global Equity Ratings PDF Download
2024/06/14 en Global Equity Ratings PDF Download


2024/08/15 17:31:33
Price
3.40 CHF
Difference -3.95% (-0.14)

General attributes

ISINIL0010855885
SymbolSHLTN
ExchangeSIX Swiss Exchange
CurrencyCHF
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)58 EUR
BenchmarkMSCI WORLD INDEX (STRD, UHD)

Market data

Bid (Bid size)3.02 CHF (8)
Ask (Ask size)3.56 CHF (1)
Open3.40 CHF
High3.53 CHF
Low3.40 CHF
Close (prev. day)3.54 CHF
VWAP3.400688 CHF
Volume (pcs)1,134
Trading volume3,856.38
Number of trades6
Last size-

Performance and Risk

6m1Y3Y
Perf (%)-40.35%-57.50%-79.76%
Perf (abs.)-2.30-4.60-13.40
Beta0.120.01-0.09
Volatility79.3773.5560.00
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)3.57 CHF (1,355)
Ø price 30 days | Ø volume 30 days (pcs.)4.02 CHF (2,185)
Ø price 100 days | Ø volume 100 days (pcs.)4.61 CHF (3,606)
Ø price 250 days | Ø volume 250 days (pcs.)6.28 CHF (4,143)
YTD High | date7.00 CHF (2024/01/03)
YTD Low | date3.40 CHF (2024/08/13)
52 Weeks High | date10.40 CHF (2023/09/29)
52 Weeks Low | date3.40 CHF (2024/08/13)

All listings for SHL TELEMEDICINE LTD

Exchange  DateTimePriceTrading volume (mio.)Number of trades
SIX Swiss Exchange2024/08/1517:313.40 CHF0.006
London Stock Exchange2024/07/0917:414.13 CHF0.011

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=11591&ID_TYPE_IMAGE_LOGO=2

Contact Details

SHL TELEMEDICINE LTD.
- -
Ashdar Building, 90 Yigal Alon Street - 67891 Tel Aviv
Telefon: +972-3-561-2212
Fax: +972-3-624-2414
E-mail: shl@shl-telemedicine.com

PDF Downloads

Company report: SHL TELEMEDICINE LTDPDF Download

Company Profile

SHL Telemedicine Ltd. engages in the development and market of advanced personal telemedicine solutions, which focuses on cardiovascular and related diseases. Its products and solutions include congestive heart failure, chronic obstructive pulmonary disease and cardiac monitoring services. It operates through the following geographical segments: Israel, Europe principally Germany, and Rest of the World. The company was founded by Yoram Alroy and Elon Shalev in 1987 and is headquartered in Tel Aviv, Israel.

Members of Management Board

Erez NachtomyChairman of Managing Board
Amir HaiMember of Executive Committee

Board of directors

Yariv AlroyChairman of Supervisory Board
Amir LermanMember of Supervisory Board
Dvora KimhiMember of Supervisory Board
Ido NeubergerMember of Supervisory Board
Nir RotenbergMember of Supervisory Board
Yehoshua AbramowitzMember of Supervisory Board





Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer